HLS Therapeutics CFO Tim Hendrickson Steps Down; Names Director John Hanna Interim CFO
(RTTNews) - Pharmaceutical company HLS Therapeutics Inc. (HLS.TO) announced Monday that Tim Hendrickson is stepping down as CFO to pursue other interests and John Hanna, currently a director of the Company, has been appointed Interim CFO.
Hendrickson will remain in his role until January 26, 2024, to support the transition and the Company will undertake a search for a permanent CFO in the new year.
While serving as Interim CFO, Hanna will remain on the HLS Board as a non-independent director
Hanna is an accomplished leader with more than 25 years of diverse experience, including in the healthcare industry. Previously, he served as CFO at Vecima Networks (VCM.TO), Inca Networks and eBuyNow and held a variety of senior financial roles with The Westaim Corp.
In addition to being a member of HLS's Board and the Audit Committee, Hanna has also served as a board member for a number of technology companies.
Canadian Dollar Advances Against Majors
Swiss Market Ends Higher For 2nd Straight Session
Major European Markets Close Slightly Weak
TSX Marches On, Hits Fresh Record High; Materials Stocks Rally
Bank Of Japan Holds Rate Steady; Plans To Lower ETF Holdings
Bay Street Likely To Open On Subdued Note
FTSE 100 Recovers After Slight Setback, Up Marginally At Noon
